Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19

Схожие документы

• Reply to: ‘No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease’
  по: Ji, Dong, et al.
  Опубликовано: (2020)
• Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study
  по: Ji, Dong, et al.
  Опубликовано: (2020)
• Response to letter to the editor by Kawada on “Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke”
  по: Parikh, Neal S., et al.
  Опубликовано: (2019)
• Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
  по: Zheng, Kenneth I., et al.
  Опубликовано: (2020)
• Reply to the Letter to the Editor “Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease”
  по: Kutlu, Orkide, et al.
  Опубликовано: (2020)